BAY2701439
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY2701439, covering 2024-09-27 to 2024-09-27. Get the full timeline:
Most recent: Clinical Trial Update: A First in Human Study of BAY2701439 to Look at Safety, How the Body Absorbs, Distributes and Excretes the Drug, and How Well the Drug Works in Participants With Advanced Cancer Expressing the HER2 Protein [Phase 1]